<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04351776</url>
  </required_header>
  <id_info>
    <org_study_id>2019-1090</org_study_id>
    <nct_id>NCT04351776</nct_id>
  </id_info>
  <brief_title>Virtual Reality and Pain</brief_title>
  <acronym>FOREVR Peds</acronym>
  <official_title>Functional Outcome Response to Engaging Virtual Reality in Pediatric Patients: a Randomized Clinical Trials</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Hospital Medical Center, Cincinnati</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Determine the impact of VR-Biofeedback, VR-distraction, and 360 video on pain and medication
      utilization in patients undergoing surgery; determine the role of anxiety and pain
      catastrophizing on changes in pain following VR-BF in patients undergoing surgery.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2020</start_date>
  <completion_date type="Anticipated">July 2024</completion_date>
  <primary_completion_date type="Anticipated">July 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>90 participants assigned to one of three groups (30 participants for each group). VR- Biofeedback, VR-Distraction, 360 Video</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of VR-biofeedback on anxiety</measure>
    <time_frame>Before 10 minute VR session.</time_frame>
    <description>Anxiety scores will be collected. Anxiety will be rated using a visual analog scale. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of VR-biofeedback on anxiety</measure>
    <time_frame>After 10 minute VR session. Anxiety will be rated using a visual analog scale.</time_frame>
    <description>Anxiety scores will be collected. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of VR-biofeedback on pain</measure>
    <time_frame>Postoperatively 24 - 90 hours.</time_frame>
    <description>Pain scores will be collected. Pain will be rated using the numerical rating scale. Participant will rate their pain from 0 - 10. 0 meaning no pain and 10 being the worst pain imaginable.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of VR-biofeedback on medication use</measure>
    <time_frame>Duration of hospital stay up to 30 days after discharge</time_frame>
    <description>Medications used will be collected</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of VR-distraction on anxiety</measure>
    <time_frame>Before 10 minute VR sesssion.</time_frame>
    <description>Anxiety scores will be collected. Anxiety will be rated using a visual analog scale. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of VR-distraction on anxiety</measure>
    <time_frame>After 10 minute VR sesssion.</time_frame>
    <description>Anxiety scores will be collected. Anxiety will be rated using a visual analog scale. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of VR-distraction on pain</measure>
    <time_frame>Postoperatively 24 - 90 hours.</time_frame>
    <description>Pain scores will be collected. Pain will be rated using the numerical rating scale. Participant will rate their pain from 0 - 10. 0 meaning no pain and 10 being the worst pain imaginable.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of VR-distraction on medication use</measure>
    <time_frame>Duration of hospital stay up to 30 days after discharge</time_frame>
    <description>Medications used will be collected</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of 360 video on anxiety</measure>
    <time_frame>Before 10 minute VR session.</time_frame>
    <description>Anxiety scores will be collected. Anxiety will be rated using a visual analog scale. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of 360 video on anxiety</measure>
    <time_frame>After 10 minute VR session.</time_frame>
    <description>Anxiety scores will be collected. Anxiety will be rated using a visual analog scale. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of 360 video on pain</measure>
    <time_frame>Postoperatively 24 - 90 hours.</time_frame>
    <description>Pain scores will be collected. Pain will be rated using the numerical rating scale. Participant will rate their pain from 0 - 10. 0 meaning no pain and 10 being the worst pain imaginable.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of 360 video on medication use</measure>
    <time_frame>Duration of hospital stay up to 30 days after discharge</time_frame>
    <description>Medications used will be collected</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Role of anxiety on changes in pain</measure>
    <time_frame>One time prior to study visit</time_frame>
    <description>Participants will complete a questionnaire regarding anxiety</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Role of pain catastrophizing</measure>
    <time_frame>One time prior to study visit</time_frame>
    <description>Participants will complete a questionnaire regarding pain</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Pain, Postoperative</condition>
  <condition>Pain</condition>
  <condition>Anxiety Postoperative</condition>
  <arm_group>
    <arm_group_label>VR-Biofeedback</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>VR-Distraction</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>360 Video</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>VR-Biofeedback</intervention_name>
    <description>Participants will be instructed to use the Mindful Aurora application</description>
    <arm_group_label>VR-Biofeedback</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>VR-Distraction</intervention_name>
    <description>Participants will be instructed to use one of three applications</description>
    <arm_group_label>VR-Distraction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>360 Video</intervention_name>
    <description>Participants will be instructed which video to view</description>
    <arm_group_label>360 Video</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ages 8 - 18 years

          -  Able to read, understand and speak English

          -  Patients in the immediate postoperative period with significant pain being followed by
             the Acute Pain Service

        Exclusion Criteria:

          -  Outside the age range (&lt; 8 or &gt; 18 years)

          -  History of developmental delays, uncontrolled psychiatric conditions, or neurological
             conditions (especially epilepsy and/or significant motion sickness/nausea/vomiting)

          -  History of vertigo, dizziness, and/or seizure disorder

          -  Conditions that would preclude the application of the VR headset, such as surgeries of
             the head and neck
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vanessa Olbrecht, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital Medical Center, Cincinnati</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vanessa Olbrecht, MD</last_name>
    <phone>513-636-4408</phone>
    <email>vanessa.olbrecht@cchmc.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kristie Geisler, BS, CCRP</last_name>
    <phone>513-636-3282</phone>
    <email>kristie.geisler@cchmc.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Vanessa Olbrecht, MD</last_name>
      <phone>513-636-4408</phone>
      <email>vanessa.olbrecht@cchmc.org</email>
    </contact>
    <contact_backup>
      <last_name>Kristie Geisler, BS, CCRP</last_name>
      <phone>513-636-3282</phone>
      <email>kristie.geisler@cchmc.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 3, 2020</study_first_submitted>
  <study_first_submitted_qc>April 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2020</study_first_posted>
  <last_update_submitted>May 20, 2020</last_update_submitted>
  <last_update_submitted_qc>May 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>This information will be made available upon request.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Data will become available upon publication. All data will be deindentified.</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

